PFA Pension Forsikringsaktieselskab Takes $62.04 Million Position in HCA Healthcare, Inc. $HCA

Key Points

• PFA Pension Forsikringsaktieselskab established a new stake in HCA, buying 131,093 shares valued at approximately $62.04 million, representing about 0.06% of the company.
• HCA reported Q EPS of $7.15 (a $0.04 miss) on $19.11 billion in revenue and set FY2026 guidance of 29.10–31.50 EPS, with analysts forecasting roughly 30.05 EPS for the year.
• The company announced a quarterly dividend of $0.78 ($3.12 annualized, ~0.7% yield), has about 62.7% institutional ownership, and carries a consensus "Moderate Buy" rating with a $520.55 price target.

PFA Pension Forsikringsaktieselskab purchased a new position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 131,093 shares of the company's stock, valued at approximately $62,041,000. PFA Pension Forsikringsaktieselskab owned approximately 0.06% of HCA Healthcare at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. Capital World Investors raised its stake in HCA Healthcare by 3.8% during the 3rd quarter. Capital World Investors now owns 4,959,336 shares of the company's stock worth $2,113,662,000 after acquiring an additional 179,443 shares in the last quarter. Arrowstreet Capital Limited Partnership raised its stake in HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company's stock worth $880,199,000 after acquiring an additional 36,414 shares in the last quarter. Viking Global Investors LP increased its stake in HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company's stock valued at $717,214,000 after purchasing an additional 690,773 shares during the period. Legal & General Group Plc increased its stake in HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company's stock valued at $479,267,000 after purchasing an additional 8,478 shares during the period. Finally, Invesco Ltd. increased its stake in HCA Healthcare by 1.1% in the third quarter. Invesco Ltd. now owns 1,100,929 shares of the company's stock valued at $469,216,000 after purchasing an additional 11,829 shares during the period. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.2%

Shares of NYSE:HCA opened at $433.73 on Friday. The firm's 50-day simple moving average is $497.66 and its 200-day simple moving average is $485.93. HCA Healthcare, Inc. has a fifty-two week low of $330.00 and a fifty-two week high of $556.52. The company has a market cap of $96.50 billion, a price-to-earnings ratio of 14.92, a PEG ratio of 1.37 and a beta of 1.19.

HCA Healthcare (NYSE:HCA - Get Free Report) last issued its earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a negative return on equity of 295.93% and a net margin of 8.89%.The company had revenue of $19.11 billion for the quarter, compared to analyst estimates of $19.09 billion. During the same quarter in the previous year, the company posted $6.45 earnings per share. The company's quarterly revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, research analysts forecast that HCA Healthcare, Inc. will post 30.05 EPS for the current year.

HCA Healthcare Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's dividend payout ratio is presently 10.73%.

Analysts Set New Price Targets

A number of research analysts have commented on the stock. Weiss Ratings restated a "buy (b)" rating on shares of HCA Healthcare in a research note on Friday, March 27th. Wall Street Zen lowered shares of HCA Healthcare from a "buy" rating to a "hold" rating in a research note on Saturday. Leerink Partners lowered their target price on shares of HCA Healthcare from $573.00 to $500.00 and set an "outperform" rating on the stock in a report on Monday, April 27th. TD Cowen lowered their target price on shares of HCA Healthcare from $561.00 to $500.00 and set a "buy" rating on the stock in a report on Monday, April 27th. Finally, Argus lifted their target price on shares of HCA Healthcare from $530.00 to $560.00 and gave the company a "buy" rating in a report on Friday, February 6th. Sixteen research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $520.55.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction that occurred on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the sale, the executive vice president directly owned 8,853 shares in the company, valued at $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total transaction of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This represents a 40.07% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 15,214 shares of company stock worth $7,797,595 over the last ninety days. 1.50% of the stock is currently owned by company insiders.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.